Association of COVID-19 case fatality rate with disease burden: an ecological analysis in Italy during the first wave

International Journal of Infectious Diseases

Giuseppina Liuzzi¹  Nicola Petrosillo²  Enrico Girardi³  Laura Timelli³  Alessandro Cannavacciuolo³  Vincenzo Puro³ 

[1] Corresponding author. Laura Timelli, “L. Spallanzani” National Institute for Infectious Diseases, IRCCS, Rome, Italy.;GcM Consulting, Turin, Italy;“L. Spallanzani” National Institute for Infectious Diseases, IRCCS, Rome, Italy;

关键词: Covid-19;    Case fatality rate;    Disease burden;   

DOI  :  

来源: DOAJ

【 摘 要 】

Objectives: In Italy, the case fatality rate (CFR) of coronavirus disease 2019 (COVID-19) during the first wave of the pandemic showed significant geographic heterogeneity. The aim of this study was to explore the possible association between the CFR and measures of disease burden in the Italian regions using an ecological approach.Methods: Cumulated regional data for the period February 24 to May 11, 2020 were analysed to assess the association of the CFR with the cumulative incidence of COVID-19 and the ratio between the maximum number of COVID-19 patients in intensive care units (ICU) and ICU beds available before the pandemic (ICU load), adjusting for median age of the patients at disease onset, number of nasopharyngeal swabs performed per confirmed case, and prevalence of chronic diseases .Results: During the study period, the COVID-19 CFR in the Italian regions ranged between 5.0% and 18.4%. On multivariable regression analysis, the CFR was found to be significantly associated with the cumulative incidence (relative rate (RR) 1.02 per 100 cases/1 million increase), median patient age (RR 1.07 per 1 year increase), and ICU load (RR 1.72, 2.18, and 2.57, for >40–70% vs ≤40%, 70–140% vs ≤40%, and ≥140 vs ≤40%, respectively).Conclusions: A high burden of COVID-19 may contribute to increased disease fatality, possibly as a result of the increasing demand for care of critically ill patients beyond health system capability.

【 授权许可】

Unknown